The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Distress in a pandemic: The association of the coronavirus disease-2019 (COVID-19) pandemic with distress and quality of life in hematopoietic stem cell transplantation (HSCT).
 
Hermioni L. Amonoo
No Relationships to Disclose
 
Carlisle E. W. Topping
No Relationships to Disclose
 
Madison A. Clay
No Relationships to Disclose
 
Thomas William LeBlanc
Honoraria - Abbvie; Astellas Pharma
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Flatiron Health; Pfizer; Seagen
Speakers' Bureau - Abbvie; Agios; Bristol-Myers Squibb; Celgene
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Jazz Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate Inc., royalty
Travel, Accommodations, Expenses - Abbvie/Genentech; Agios; Celgene
 
Joseph A. Greer
Research Funding - Gaido Health/BCG Digital Ventures (Inst); NCCN/AstraZeneca (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Springer Publishing Company for edited book, "The Massachusetts General Hospital Handbook of Behavioral Medicine."
 
Stephanie Lee
Honoraria - Wolters Kluwer (I)
Consulting or Advisory Role - 4SC (I); EMD Serono (I); Genzyme (I); Incyte; Kadmon; MSD Oncology (I); Pfizer; Pfizer (I); Regeneron (I); Sanofi (I)
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb (I); EMD Serono (I); Incyte; Kadmon; MSD (I); Novartis; Pfizer; Syndax; Takeda
Patents, Royalties, Other Intellectual Property - Patent pending for high affinity T cell receptors that target the Merkel polyomavirus (I)
 
Jennifer Temel
No Relationships to Disclose
 
Areej El-Jawahri
No Relationships to Disclose